Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Ardeparin: Difference between pages
Appearance
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 461572631 of page Ardeparin_sodium for the Chem/Drugbox validation project (updated: 'DrugBank', 'UNII', 'ChEMBL'). |
Citation bot (talk | contribs) Added date. | Use this bot. Report bugs. | Suggested by Whywhenwhohow | #UCB_webform 94/1421 |
||
Line 1: | Line 1: | ||
{{Short description|Pharmaceutical drug}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Ardeparin_sodium|oldid=461572631}} 461572631] of page [[Ardeparin_sodium]] with values updated to verified values.}} |
|||
{{Use dmy dates|date=March 2024}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
| Watchedfields = changed |
| Watchedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = |
||
| IUPAC_name = 6-[5-acetylamino-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-3-[5-(6- |
| IUPAC_name = 6-[5-acetylamino-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-3-[5-(6- |
||
| image = Ardeparin.png |
| image = Ardeparin.png |
||
| width = 450 |
| width = 450 |
||
| alt = |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| Drugs.com = {{drugs.com|MTM| |
| Drugs.com = {{drugs.com|MTM|}} |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
⚫ | |||
| pregnancy_US = C |
|||
⚫ | |||
⚫ | |||
| ATC_prefix = None |
|||
⚫ | |||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> |
||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> |
||
| legal_US = |
| legal_US = Rx-only |
||
| legal_US_comment = |
|||
| legal_status = |
| legal_status = |
||
⚫ | |||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = 92% |
| bioavailability = 92% |
||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct| |
| CAS_number_Ref = {{cascite|correct|}} |
||
| CAS_number = |
| CAS_number = |
||
| |
| = |
||
⚫ | |||
| PubChem = |
|||
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
||
| DrugBank = |
| DrugBank = DB00407 |
||
⚫ | |||
| UNII = <!-- blanked - oldvalue: N3927D01PB --> |
|||
⚫ | |||
| ChEMBL = <!-- blanked - oldvalue: 1201448 --> |
|||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
||
| ChemSpiderID = |
| ChemSpiderID = |
||
⚫ | |||
| UNII = N3927D01PB |
|||
⚫ | |||
| ChEMBL = 1201448 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| chemical_formula = (C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>36</sub>S<sub>5</sub>)<sub>n</sub> |
| chemical_formula = (C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>36</sub>S<sub>5</sub>)<sub>n</sub> |
||
| molecular_weight = 5500–6500 |
| molecular_weight = 5500–6500 (average) |
||
}} |
}} |
||
'''Ardeparin''' (brand name '''Normiflo''') is an [[anticoagulant]]. It was used for the prevention of [[deep vein thrombosis]], but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy.<ref>{{cite book | vauthors = Frishman WH, Cheng-Lai A, Chen J |title=Current cardiovascular drugs |date=2000 |publisher=Current Medicine |location=Philadelphia, Pa. |isbn=978-1-4615-6767-7 |page=90 |edition=3rd | chapter = Antithrombotic therapy | chapter-url=https://books.google.com/books?id=zP7jBwAAQBAJ&pg=PA90 }}</ref><ref>{{cite web | work = Drugs.com | url = https://www.drugs.com/mtm/normiflo.html | title = Normiflo | access-date = 23 January 2018 | archive-date = 19 February 2017 | archive-url = https://web.archive.org/web/20170219170906/https://www.drugs.com/mtm/normiflo.html | url-status = dead }}</ref><ref>{{cite web |title=Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |url=https://www.federalregister.gov/d/02-12874 |website=United States Food and Drug Administration |date=23 May 2002 |publisher=Federal Register |access-date=24 June 2022}}</ref> |
|||
==References== |
|||
{{reflist}} |
|||
{{Antithrombotics}} |
|||
{{Portal bar | Medicine}} |
|||
[[Category:Heparins]] |
|||
[[Category:Withdrawn drugs]] |
|||
{{blood-drug-stub}} |